124 related articles for article (PubMed ID: 24858621)
1. Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma.
Zhang J; Tu K; Yang W; Li C; Yao Y; Zheng X; Liu Q
Mol Med Rep; 2014 Aug; 10(2):749-54. PubMed ID: 24858621
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. [Gli1 expression and its relationship with the expression of Shh, Vimentin and E-cadherin in human hepatocellular carcinoma].
Xu QR; Zheng X; Zan XF; Yao YM; Yang W; Liu QG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 May; 28(5):536-9. PubMed ID: 22558994
[TBL] [Abstract][Full Text] [Related]
4. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
5. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
7. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma.
Wang JH; Wei W; Xu J; Guo ZX; Xiao CZ; Zhang YF; Jian PE; Wu XL; Shi M; Guo RP
Oncotarget; 2015 Oct; 6(33):35116-28. PubMed ID: 26375669
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.
Zhang Z; Meng G; Wang L; Ma Y; Guan Z
Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
11. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
13. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
[TBL] [Abstract][Full Text] [Related]
14. Mastermind-like Transcriptional Coactivator 1 Overexpression Predicts Poor Prognosis in Human with Hepatocellular Carcinoma.
Wang J; Zhang SM; Wu JM; Lu ZC; Yang JR; Wu HS; Chen H; Lin B; Xu RH; Cao TS
Ann Clin Lab Sci; 2016 Sep; 46(5):502-7. PubMed ID: 27650617
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma.
Ye K; Wang Z; Zhang G; Liang S
J Invest Surg; 2010 Jun; 23(3):163-9. PubMed ID: 20590388
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
20. Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma.
Liu Y; Hu C; Zhu WB; Xu WX; Li ZY; Lin Y; Cai J; Liang JK; Zhu X; Gao ZL; Yan GM; Peng L
Cell Physiol Biochem; 2018; 49(3):1007-1018. PubMed ID: 30196292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]